Scientists warn of negative effects of Alzheimer's drugs
2/20/2024, 5:21:17 AM
Highlights: Scientists warn of negative effects of Alzheimer's drugs. Scientists in the study expressed their concern about the insufficient results of clinical trials of two ‘revolutionary’ drugs. Lecanemab, developed by the Japanese company Eisai and its American partner Biogen, and donanemab,. produced by the American company Lilly. These drugs can lead to a slowdown in cognitive decline, which clears the brain of a toxic protein, which is considered the main sign of Alzheimer’s disease.
Scientists in the study expressed their concern about the insufficient results of clinical trials of two “revolutionary” drugs for the treatment of Alzheimer's disease: lecanemab, developed by the Japanese company Eisai and its American partner Biogen, and donanemab, produced by the American company Lilly.
The Times newspaper writes about this.
According to scientific research, these drugs can lead to a slowdown in cognitive decline, which clears the brain of a toxic protein, which is considered the main sign of Alzheimer's disease.
However, as the material notes, medications can lead to serious side effects, including brain shrinkage and bleeding.
Earlier, the head of the neurology and rehabilitation service of the Vladimirsky MONIKI, the chief freelance neurologist of the Ministry of Health of the Moscow Region, Maxim Sutormin, spoke about the trend towards “rejuvenation” of stroke.